Search results
Results from the WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
Delamanid is sold under the brand name Deltyba, is a medication used to treat tuberculosis. [2] Specifically it is used, along with other antituberculosis medications, for active multidrug-resistant tuberculosis. [2] It is taken by mouth. [2] There are common side effects which include headache, dizziness, and nausea. [3]
Ethionamide is an antibiotic used to treat tuberculosis. [2] Specifically it is used, along with other antituberculosis medications, to treat active multidrug-resistant tuberculosis. [2] It is no longer recommended for leprosy. [3] [2] It is taken by mouth. [2] Ethionamide has a high rate of side effects. [4]
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.
Isoniazid and a related drug, iproniazid, were among the first drugs to be referred to as antidepressants. [11] Psychiatric use stopped in 1961 following reports of hepatotoxicity. Use against tuberculosis continued, as isoniazid's effectiveness against the disease outweighs its risks. [12]
Totally drug-resistant TB is resistant to all currently used drugs. [156] It was first observed in 2003 in Italy, [157] but not widely reported until 2012, [156] [158] and has also been found in Iran and India. [159] There is some efficacy for linezolid to treat those with XDR-TB but side effects and discontinuation of medications were common ...
For active tuberculosis it is often given together with isoniazid, rifampicin, and pyrazinamide. [4] It is administered by injection into a vein or muscle. [3] Common side effects include vertigo, vomiting, numbness of the face, fever, and rash. [3] Use during pregnancy may result in permanent deafness in the developing baby. [3]
This page was last edited on 6 December 2023, at 11:04 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.